Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177

J Acquir Immune Defic Syndr. 2010 Aug;54(4):e7-9. doi: 10.1097/QAI.0b013e3181e2d5e5.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / therapy
  • Anti-HIV Agents / pharmacokinetics
  • Anti-HIV Agents / therapeutic use
  • Combined Modality Therapy
  • HIV Infections / drug therapy*
  • HIV Infections / therapy*
  • HIV-1
  • Nevirapine / pharmacokinetics*
  • Nevirapine / therapeutic use
  • Renal Dialysis*

Substances

  • Anti-HIV Agents
  • Nevirapine